Trial Profile
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multicenter Study of the Safety and Efficacy of Avanafil in the Treatment of Erectile Dysfunction Following Bilateral Nerve-Sparing Radical Prostatectomy
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 10 Dec 2021
Price :
$35
*
At a glance
- Drugs Avanafil (Primary)
- Indications Erectile dysfunction
- Focus Registrational; Therapeutic Use
- Acronyms REVIVE-RP
- 26 Jun 2013 Avanafil approved for treatment of erectile dysfunction in the EU based on results of the RIVIVE, REVIVE-Diabetes and REVIVE-RP, according to a VIVUS media release.
- 28 Mar 2012 Additional lead trial centres and investigator (Chuck Bowden) identified as reported by ClinicalTrials.gov.
- 28 Mar 2012 Additional lead trial centres and investigator (Chuck Bowden) identified as reported by ClinicalTrials.gov.